R. Borawska

发表

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis

J. Kochanowicz, B. Mroczko, A. Kułakowska, 2022, Journal of clinical medicine.

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis

A. Słowik, B. Mroczko, M. Dulewicz, 2022, International journal of molecular sciences.

Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia.

A. Słowik, B. Mroczko, Magdalena Groblewska, 2020, Current Alzheimer research.

The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases

A. Słowik, J. Kochanowicz, B. Mroczko, 2021, Journal of Clinical Medicine.

The cerebrospinal fluid interleukin 8 (IL‐8) concentration in Alzheimer’s disease (AD)

A. Słowik, B. Mroczko, M. Dulewicz, 2021, Alzheimer's & Dementia.

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease

A. Słowik, B. Mroczko, M. Dulewicz, 2021, Journal of clinical medicine.

The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.

A. Słowik, P. Muszyński, B. Mroczko, 2017, Journal of Alzheimer's disease : JAD.

Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease.

P. Lewczuk, J. Kornhuber, P. Muszyński, 2014, Journal of Alzheimer's disease : JAD.

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease

A. Słowik, B. Mroczko, M. Dulewicz, 2021, Journal of clinical medicine.

Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

A. Słowik, B. Mroczko, Monika Zajkowska, 2023, Journal of clinical medicine.

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease

K. Blennow, H. Zetterberg, A. Słowik, 2023, International journal of molecular sciences.

Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease

K. Blennow, B. Mroczko, M. Dulewicz, 2024, International journal of molecular sciences.